News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Byrnes Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/16/2023 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 4,863 shares
@ $0.459, valued at
$2.2k
|
|
| 01/19/2023 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.47, valued at
$235k
|
|
| 11/16/2022 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 4,651 shares
@ $0.4684, valued at
$2.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2022 |
4
| Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.|
Txns:
| Granted 235,541 options to buy
@ $6.65, valued at
$1.6M
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/11/2017 |
4
| Byrnes Michael (CFO and Treasurer) has filed a Form 4 on Ocera Therapeutics, Inc.|
Txns:
| Disposed/sold 13,000 shares
@ $1.52, valued at
$19.8k
Disposed/sold 150,000 shares
@ $1.52, valued at
$228k
Disposed/sold 123,300 options to buy
@ $2.98, valued at
$367.4k
Disposed/sold 55,000 options to buy
@ $7.5, valued at
$412.5k
Disposed/sold 75,000 options to buy
@ $3.76, valued at
$282k
Disposed/sold 102,300 options to buy
@ $2.15, valued at
$219.9k
Disposed/sold 70,000 options to buy
@ $7.5, valued at
$525k
|
|
| 03/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|